Page 103 - Cute News Today

Bored Panda works better on our iPhone app Continue in appContinue in browser Like what youre reading? Subscribe to our top stories Please enter email address We will not spam you Almost finished... Like what youre seeing? Lets keep in touch and well send more your way. Please enter email address By submitting email you agree to get Bored Panda newsletter. We respect your privacy. We will not publish or share your email address in any way. Almost finished... Almost finished... Ar...

Merck Foundation, the philanthropic arm of Merck KGaA Germany marks World Hypertension Day 2021 in partnership with African First Ladies, Ministries of Health, Medical Societies and Academia, through their long-term commitment towards building Cardiovascular, Diabetes, and Endocrinology care capacity in Africa, Asia, and Latin America.

Tiger cubs and other cute animals opening presents at Taronga Zoo... youre welcome 23rd Dec 2013 2:39am | By Editor So what got you in? Cute animals or the presents? A mighty duo, we know. Every year the animals at Taronga Park Zoo in Sydney get gifts in the form of treats and puzzles, and as you see from the photos theyre pretty happy about it.  The zoo calls it behavioural enrichment, and such things are used in stimulating their minds and triggering natural instincts.  But bec...

(0) Altasciences is pleased to support SiteOne Therapeutics with a Phase I, randomized, double-blind, placebo-controlled study in healthy adults to evaluate the safety, tolerability, and pharmacokinetics of ST-2427. ST-2427 is a highly selective inhibitor of NaV1.7 for the management of moderate-to-severe pain; by selectively targeting NaV1.7, ST-2427 aims to stop the electrical signals responsible for pain before they reach the central nervous system. Amy Denvir, General Manager of Altasci...

WESTON (dpa-AFX) - Neuroscience company Biogen Inc (BIIB) announced Wednesday that it has exercised its option to acquire TMS-007, an investigational drug for acute ischemic stroke, from privately-held

(0) TMS-007 has the potential to be a next generation thrombolytic with an improved benefit-risk profile Acute ischemic stroke is caused by a blockage of blood supply to the brain, and current thrombolytics are limited in use due in part to increased risks of bleeding Phase 2a study demonstrated positive impacts on blood vessel reopening and patient functional recovery with no incidence of symptomatic intracranial hemorrhage Biogen to make a one-time payment of $18 million and may pay potenti...

Dr. Pepper, a 22-year-old cat, is in need of a new home. The Animal Welfare League of Arlington put out a call on social media on Wednesday in hopes of finding this very elderly, brown and black, domestic shorthaired kitty a welcoming place to nap and snack. She was brought into the shelter about two weeks ago, Chelsea Jones of AWLA said, when her long-time caretaker had become too sick to care for her anymore. Dr. Pepper was accompanied by a note that said she was the beloved companion of a ca...

ESTEVE and KOWA Pharmaceuticals America enter into an Exclusive License and Commercialization Agreement for rights to E-58425 for the potential management of acute pain(1-9) in the United States(8,9) celecoxib and tramadol (8,9) BARCELONA, Spain, May 3, 2021 /PRNewswire/ -- Esteve Pharmaceuticals (ESTEVE), an international specialty pharmaceutical company devoted to the development and commercialization of innovative products, today announced an agreement with Kowa Pharmaceuticals America, Inc....

Bored Panda works better on our iPhone app Continue in appContinue in browser Like what youre reading? Subscribe to our top stories Please enter email address We will not spam you Almost finished... Like what youre seeing? Lets keep in touch and well send more your way. Please enter email address By submitting email you agree to get Bored Panda newsletter. We respect your privacy. We will not publish or share your email address in any way. Almost finished... Almost finished... Ar...

Vifor Pharma and Angion announce completion of enrollment in phase-II study of ANG-3777 for cardiac-surgery associated acute kidney injury Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210428005922/en/ Vifor Pharma and Angion Biomedica Corp. (NASDAQ: ANGN), today announced completion of enrollment for Angions AKI-002-15 study, a phase-II trial of ANG-3777 in patients at risk of cardiac-surgery associated acute kidne...